Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b]pyridazines, related compounds, and their use in the treatment of medical disorders | Patent Number 11878979

US 11878979 B2
Application Number17385269
Publication NumberUS 20220185814 A1
Pendency2 years, 6 months, 1 day
Filled DateJul 26, 2021
Priority DateMay 5, 2016
Publication DateJun 16, 2022
Expiration DateMay 4, 2036
Inventor/ApplicantsPeter T. Lansbury
William J. Greenlee
Elyse Marie Josee Bourque
Renato T. Skerlj
ExaminesKIFLE, BRUCK
Art Unit1624
Technology Center1600
Assignments
Lysosomal Therapeutics Inc.
Current
Bialr&d Investments S.a.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.